HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Yoshino Selected Research

Lipopolysaccharides

4/2016Soluble form of the receptor for advanced glycation end-products attenuates inflammatory pathogenesis in a rat model of lipopolysaccharide-induced lung injury.
10/2006Stimulation of alpha7 nicotinic acetylcholine receptor inhibits CD14 and the toll-like receptor 4 expression in human monocytes.
11/2005Beta2-adrenergic receptor stimulation inhibits LPS-induced IL-18 and IL-12 production in monocytes.
9/2004Inducible histamine protects mice from P. acnes-primed and LPS-induced hepatitis through H2-receptor stimulation.
2/2003Histamine inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production in an intercellular adhesion molecule-1- and B7.1-dependent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Yoshino Research Topics

Disease

57Neoplasms (Cancer)
02/2023 - 04/2002
55Lymphoma (Lymphomas)
01/2024 - 02/2002
29Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2023 - 04/2002
27Immunoglobulin G4-Related Disease
12/2020 - 12/2009
19Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2023 - 12/2003
18Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2022 - 12/2003
16Inflammation (Inflammations)
01/2023 - 09/2002
16B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 05/2003
15Lymphadenopathy
01/2023 - 06/2008
12Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2024 - 05/2003
12Infections
01/2023 - 08/2005
12Multi-centric Castleman's Disease
10/2019 - 01/2004
11Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 12/2003
8T-Cell Lymphoma (Lymphoma, T Cell)
09/2022 - 06/2003
7Thrombocytopenia (Thrombopenia)
11/2022 - 11/2005
7Anemia
03/2020 - 11/2005
7Carcinoma (Carcinomatosis)
04/2017 - 07/2010
7Lung Neoplasms (Lung Cancer)
01/2017 - 03/2002
6Hodgkin Disease (Hodgkin's Disease)
01/2024 - 11/2011
6Carcinogenesis
02/2023 - 09/2008
6Fibrosis (Cirrhosis)
10/2019 - 01/2013
6Autoimmune Diseases (Autoimmune Disease)
01/2019 - 04/2002
6Leukemia
11/2017 - 11/2002
6Sepsis (Septicemia)
07/2016 - 02/2003
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2023 - 04/2010
5Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
11/2020 - 02/2002
5Castleman Disease (Castleman's Disease)
03/2020 - 12/2012
5Edema (Dropsy)
10/2019 - 01/2013
5Rheumatoid Arthritis
01/2018 - 01/2012
5Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2017 - 06/2003
5Adenocarcinoma
10/2013 - 03/2002
4Spontaneous Remission
01/2022 - 06/2017
4Fever (Fevers)
10/2019 - 01/2013
4Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019 - 06/2008
4Hypoalbuminemia
11/2017 - 01/2012
3Ulcer
11/2021 - 09/2005
3Diabetes Complications
01/2020 - 03/2010
3Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2015 - 08/2002
3Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell)
02/2015 - 08/2011
3Pathologic Complete Response
01/2015 - 01/2008
3Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2014 - 02/2002

Drug/Important Bio-Agent (IBA)

25Immunoglobulin G (IgG)IBA
04/2021 - 01/2004
20Proteins (Proteins, Gene)FDA Link
01/2024 - 11/2002
15Rituximab (Mabthera)FDA Link
02/2021 - 01/2008
13Immunoglobulins (Immunoglobulin)IBA
12/2022 - 04/2002
13ParaffinIBA
04/2020 - 01/2003
12Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
09/2021 - 09/2004
11Methotrexate (Mexate)FDA LinkGeneric
01/2024 - 05/2009
11Interleukin-6 (Interleukin 6)IBA
12/2020 - 02/2002
10CytokinesIBA
01/2023 - 01/2004
10AntigensIBA
12/2018 - 11/2003
9InterleukinsIBA
03/2020 - 11/2005
8Interleukin-2 Receptors (IL 2 Receptor)IBA
03/2023 - 07/2009
7Prednisone (Sone)FDA LinkGeneric
01/2021 - 06/2005
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2021 - 06/2005
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 06/2005
7Vincristine (Oncovin)FDA LinkGeneric
01/2021 - 06/2005
7Cyclin D1IBA
11/2017 - 01/2008
7Interleukin-18 (Interleukin 18)IBA
08/2006 - 09/2002
6Monoclonal AntibodiesIBA
01/2023 - 12/2007
6Messenger RNA (mRNA)IBA
01/2023 - 11/2002
6Immunoglobulin A (IgA)IBA
12/2020 - 04/2002
6DNA (Deoxyribonucleic Acid)IBA
12/2020 - 09/2009
6C-Reactive ProteinIBA
03/2020 - 04/2009
6Formaldehyde (Formol)FDA Link
03/2018 - 05/2003
6Immunoglobulin E (IgE)IBA
01/2018 - 01/2004
6HMGB1 Protein (HMG1)IBA
01/2017 - 12/2007
5AntibodiesIBA
01/2023 - 06/2004
5SteroidsIBA
03/2019 - 11/2005
5T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2018 - 04/2009
5Immunoglobulin M (IgM)IBA
06/2017 - 04/2002
5LipopolysaccharidesIBA
04/2016 - 02/2003
4Advanced Glycation End ProductsIBA
11/2021 - 03/2010
4glycolaldehydeIBA
11/2021 - 09/2009
4Cytidine DeaminaseIBA
04/2021 - 07/2009
4Indicators and Reagents (Reagents)IBA
04/2020 - 01/2014
4Biomarkers (Surrogate Marker)IBA
03/2020 - 01/2010
4Reticulin (Reticular Fiber)IBA
10/2019 - 01/2013
4Interleukin-1 (Interleukin 1)IBA
01/2018 - 01/2015
4Anaplastic Lymphoma KinaseIBA
12/2017 - 06/2003
4ErbB Receptors (EGF Receptor)IBA
01/2017 - 09/2008
3Anti-Bacterial Agents (Antibiotics)IBA
04/2023 - 10/2015
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2023 - 11/2012
3Cisplatin (Platino)FDA LinkGeneric
02/2023 - 03/2002
3Prednisolone (Predate)FDA LinkGeneric
01/2023 - 09/2017
3CyclinsIBA
01/2023 - 11/2011
3LigandsIBA
01/2022 - 01/2019
3GlyceraldehydeIBA
01/2020 - 09/2009
3Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA
03/2019 - 01/2012
3Etoposide (VP 16)FDA LinkGeneric
12/2017 - 09/2002
3Interleukin-4 (Interleukin 4)IBA
12/2015 - 01/2004
3RNA (Ribonucleic Acid)IBA
10/2015 - 11/2008

Therapy/Procedure

36Therapeutics
01/2023 - 08/2002
22Drug Therapy (Chemotherapy)
07/2022 - 03/2002
12Radiotherapy
10/2022 - 06/2005
5Chemoradiotherapy
11/2014 - 12/2003
4Transplantation
09/2022 - 04/2002
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2003 - 04/2002
3Gastrectomy
04/2018 - 06/2005
3Ligation
07/2016 - 03/2010